kidney disease

Original Contribution

First Clinical Experience With Targeted REnal Nerve Demodulation (TREND-1) Using a Neurotropic Agent for the Treatment of Sympathetic Hypertension

01/15/2017

Mark Wholey , MD;

Emily Stein , PhD;

Venkateswara Rao , PhD;

Nicholas Kipshidze , MD, PhD;

Michael H. Wholey , MD, MBA;

Konstantin Kipiani , MD;

Horst Sievert , MD, FESC, FACC, FSCAI;

Vakhtang Kipiani , MD;

Tea Mukhuradze , MD;

An evaluation of the feasibility and safety of a novel targeted neuromodulatory treatment for sympathetic hypertension involving a one-time local injection of neurotropic agents near renal nerves.

An evaluation of the feasibility...

01/15/2017

Journal of Invasive Cardiology

Original Contribution

Impact of Impaired Renal Function in Patients With Severely Calcified Coronary Lesions Treated With Orbital Atherectomy

01/15/2017

Richard A. Shlofmitz , MD;

Evan Shlofmitz , DO;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Gentian Lluri , MD, PhD;

We evaluated the clinical outcomes of patients with chronic kidney disease who underwent orbital atherectomy for severe coronary artery calcification prior to stent implantation.

We evaluated the clinical...

01/15/2017

Journal of Invasive Cardiology